Completed NA INTERVENTIONAL 2-arm NCT02009982

Cardioneuroablation for Neurocardiogenic Syncope (Ablate-NCS)

Sponsor: Biosense Webster, Inc.

Conditions Neurocardiogenic Syncope Vasovagal Syncope

Interventions Biosense Webster Navistar ThermoCool Diagnostic/Ablation Deflectable Tip Catheter Cardioneuroablation

Updated 9 times since 2017 Last updated: Sep 16, 2016 Started: Dec 31, 2013 Primary completion: Dec 31, 2015 Completion: Dec 31, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Neurocardiogenic Syncope and Vasovagal Syncope and is currently completed. Biosense Webster, Inc. leads this study, which shows 9 recorded versions since 2013 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

9 versions recorded

Jan 2026 — Present [monthly]

Completed NA
Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2023 — Jul 2024 [monthly]

Completed NA
Dec 2022 — Jan 2023 [monthly]

Completed NA

▶ Show 4 earlier versions

Jan 2021 — Dec 2022 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Feb 2017 — Jun 2018 [monthly]

Completed NA
Jan 2017 — Feb 2017 [monthly]

Completed NA

First recorded

Dec 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Biosense Webster, Inc.
David B. De Lurgio

Data source: Emory University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Atlanta, United States
• Chapel Hill, United States